AAAAAA

   
Results: 1-7 |
Results: 7
PHASE-II TRIAL OF THE MULTITARGETED ANTIFOLATE MTA (LY231514) IN PATIENTS WITH NONSMALL CELL LUNG-CANCER (NSCLC) WHO HAVE FAILED PREVIOUS PLATINUM OR NONPLATINUM CHEMOTHERAPY
Authors: MATTSON K MANEGOLD C POSTMUS P SMIT E MILLWARD M SAARINEN A
Citation: K. Mattson et al., PHASE-II TRIAL OF THE MULTITARGETED ANTIFOLATE MTA (LY231514) IN PATIENTS WITH NONSMALL CELL LUNG-CANCER (NSCLC) WHO HAVE FAILED PREVIOUS PLATINUM OR NONPLATINUM CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 472-472
TOPOTECAN, A NEW ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY IN PATIENTS WITH REFRACTORY AND SENSITIVE DISEASE
Authors: ARDIZZONI A HANSEN H DOMBERNOWSKY P GAMUCCI T KAPLAN S POSTMUS P GIACCONE G SCHAEFER B WANDERS J VERWEIJ J
Citation: A. Ardizzoni et al., TOPOTECAN, A NEW ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY IN PATIENTS WITH REFRACTORY AND SENSITIVE DISEASE, Journal of clinical oncology, 15(5), 1997, pp. 2090-2096
SMALL-CELL LUNG-CANCER
Authors: IHDE D SOUHAMI B COMIS R GREGOR A HANSEN H JOHNSON B MURRAY N POSTMUS P ROCMANS P SAIJO N STOUT R TURRISI A WAGNER H
Citation: D. Ihde et al., SMALL-CELL LUNG-CANCER, Lung cancer, 17, 1997, pp. 19-21
RANDOMIZED COMPARISON OF ALTERNATING OR SEQUENTIAL SCHEDULES OF CHEMORADIOTHERAPY IN LIMITED SMALL-CELL LUNG-CANCER (SCLC) TRIAL OF THE EORTC LCCG(08877)
Authors: GREGOR A DRINGS P POSTMUS P BURGHOUTS J MORGAN D KIRPATRICK A SAHMOUD T GIACCONE G
Citation: A. Gregor et al., RANDOMIZED COMPARISON OF ALTERNATING OR SEQUENTIAL SCHEDULES OF CHEMORADIOTHERAPY IN LIMITED SMALL-CELL LUNG-CANCER (SCLC) TRIAL OF THE EORTC LCCG(08877), European journal of cancer, 31A, 1995, pp. 77-77
EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT
Authors: BUNN PA VANZANDWIJK N PASTORINO U AISNER J ALBERTO P ARRIAGADA R CARNEY D CORNIS R DITTRICH C GATZEMEIER U GINSBERG R GRECO FA HANSEN HH HARPER P HENRIKSSON R HUBER H KLENER P LECHEVALIER T LEWENSOHN R MURRAY N NIEDERLE N POSTMUS P ROSELL R SCAGLIOTTI G SCULIER JP SPLINTER T STAHEL R SYMANN M THATCHER N TONATO M TURRISI A
Citation: Pa. Bunn et al., EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT, European journal of cancer, 30A(5), 1994, pp. 710-713
INDUCTION THERAPY FOR STAGE-III NSCLC - A CONSENSUS REPORT
Authors: GREEN MR GINSBERG R ARDIZZONI A CHOI N DARWISH S FUKUOKA M GINER V GRUNENWALD D HARPER P KHO S LECHEVALIER T LEWINSKI T PAYNE D POSTMUS P ROCMANS P ROSELL R ROTH J SCULIER JP SORENSEN JB
Citation: Mr. Green et al., INDUCTION THERAPY FOR STAGE-III NSCLC - A CONSENSUS REPORT, Lung cancer, 11, 1994, pp. 9-10
PRELIMINARY-RESULTS OF 2 DOSE-FINDING STUDIES OF PACLITAXEL (TAXOL) AND CARBOPLATIN IN NONSMALL CELL LUNG AND OVARIAN CANCERS - A EUROPEAN-CANCER-CENTER EFFORT
Authors: GIACCONE G HUIZING M HUININK WT KOOLEN M POSTMUS P VANKRALINGEN K VANZANDWIJK N VERMORKEN J BEIJNEN J DALESIO O PINEDO H VEENHOF C
Citation: G. Giaccone et al., PRELIMINARY-RESULTS OF 2 DOSE-FINDING STUDIES OF PACLITAXEL (TAXOL) AND CARBOPLATIN IN NONSMALL CELL LUNG AND OVARIAN CANCERS - A EUROPEAN-CANCER-CENTER EFFORT, Seminars in oncology, 21(5), 1994, pp. 34-38
Risultati: 1-7 |